CPC C07K 16/2863 (2013.01) [A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 16/30 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/52 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/70 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01)] | 16 Claims |
1. A monoclonal antibody or antigen-binding fragment thereof that binds to human MET, wherein the antibody or antigen-binding fragment thereof comprises:
a. a light chain variable region (“VL”) comprising:
i. a VL CDR1 comprising the amino acid sequence of SEQ ID NO: 13;
ii. a VL CDR2 comprising the amino acid sequence of SEQ ID NO: 14; and
iii. a VL CDR3 comprising the amino acid sequence of SEQ ID NO: 15; and
b. a heavy chain variable region (“VH”) comprising:
i. a VH CDR1 comprising the amino acid sequence of SEQ ID NO: 16;
ii. a VH CDR2 comprising the amino acid sequence of SEQ ID NO: 17; and
iii. a VH CDR3 comprising the amino acid sequence of SEQ ID NO: 18.
|